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Abstract 
In recent years, magnesium and magnesium alloys have received much attention as a new 
biomaterial in orthopaedic applications due to their biodegradability, biocompatibility, and their 
mechanical properties that are similar to natural bone tissue. The most common problem 
associated with magnesium as a biomaterial is low corrosion resistance in physiological 
solutions. This decreases the mechanical integrity of the implants in the early stages of healing 
and has a negative impact on the overall biocompatibility. The main goal of this study was to 
create a multi-layered coating consisting of a silica sol-gel under-layer to protect the substrate 
from corrosion in body fluids and a mesoporous silica top-layer to enhance the bioactivity of the 
coated implant material. 
The results indicate that the deposited multi-layered coating enhances both the bioactivity and 
the corrosion resistance of the material. 
Keywords  
Biomaterials, biodegradable, orthopaedic implants, magnesium alloys, corrosion resistance, 
bioactivity, silane coating, mesoporous silica coating 
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Chapter 1  
 « Introduction » 1
Synthetic materials have been used extensively in medical applications. Materials used 
for these applications are known as biomaterials. The term biomaterial has been defined 
by the European Society for Biomaterials Consensus Conference as “A material intended 
to interface with biological systems to evaluate, treat, augment or replace any tissue, 
organ, or function of the body” [1]. 
Biomaterials are used in the replacement and treatment of diseased or injured tissue in 
different parts of the body; some examples include cardiovascular, dental and orthopaedic 
implants [3]. The development of biomaterials for orthopaedic applications has been a 
significant challenge to biomaterials scientists. The optimum biomaterials for orthopaedic 
implants should be non-toxic and biocompatible with the human body [2]. Furthermore, 
they should have excellent mechanical properties for the intended application and under 
some circumstances these biomaterials should be biodegradable to prevent the need for 
additional surgery to remove the implant after healing has occurred [4]. 
Biomaterials can be classified according to their structural, chemical, and biological 
properties. Orthopaedic biomaterials are classified as bioinert, bioactive or bidegradable 
depending on how they interface with the body tissue [5]. The term bioinert refers to any 
materials such as stainless steel, alumina and titanium which are designed to have 
minimal interaction with the surrounding tissue when they are placed in the human body.  
On the other hand, bioactive biomaterials such as synthetic hydroxyapatite, glass-ceramic 
A-W and bioglass
® 
are designed to specifically interact with the surrounding tissue 
during implantation resulting in the formation of a hydroxyapatite layer on the implant 
surface that enhances the biocompatibility of the material. Finally, biodegradable 
biomaterials such as tricalcium phosphate, synthetic polymers and magnesium are 
materials that are designed to dissolve or degrade after the tissue has healed [6]. 
However, these biodegradable biomaterials need to maintain their mechanical properties 
2 
 
until the implant is no longer needed and then they must be absorbed and eliminated from 
the body as non-toxic degradation products [7].  
 Magnesium and its Alloys as Orthopaedic Biomaterials 1.1
Magnesium alloys have the highest strength/weight ratio of all known structural metals. 
They are a third lighter than aluminum and a quarter the density of steel [8]. In recent 
years, magnesium and its alloys have received much attention as potential orthopaedic 
biomaterials due to their excellent biocompatibility, biodegradability, and mechanical 
properties that are similar to natural bone. These properties have made magnesium alloys 
a promising alternative for biodegradable orthopaedic implants that decrease stress 
shielding and enhance new bone growth [8-9]. 
1.1.1 Biocompatibility of Magnesium 
Magnesium is the fourth most abundant inorganic element in the human body. The 
average adult human body weighs around 70 kg and contains from 21 – 28 g of 
magnesium [10-11]; 50 percent of this total body magnesium is stored in the skeletal 
system. To maintain appropriate magnesium levels in the body, humans need to absorb 
between 300 to 400 mg of magnesium daily [11]. Moreover, magnesium is also essential 
to human metabolic functions such as DNA/RNA stabilization and it acts as a co-factor 
for more than 300 different enzymatic reactions. It has also been shown to promote bone 
cell attachment and tissue growth on implant materials [8-12]. Magnesium influences 
many biological functions within the body and plays a very important role within the cell 
[13-14], therefore, it can be concluded that magnesium is non-toxic. 
1.1.2 Biodegradability of Magnesium 
Metallic materials such as stainless steel, cobalt-based alloys and titanium alloys are 
widely used as biomaterials due to their flexibility, high strength and excellent corrosion 
resistance. However, these implants are not biodegradable in the human body. Toxic ions 
can be released when these implants corrode, which results in inflammation and tissue 
loss [15]. Furthermore, in some cases, such as fracture fixation, these metallic implants 
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are only needed for a short time until the healing process has occurred. This means that a 
second surgery may be necessary to remove the implant after tissue healing [15-16]. 
Biodegradable metallic materials that can provide the required stability during the initial 
stages of healing and promote tissue regeneration as they degrade would eliminate both 
the toxic corrosion products associated with traditional metallic implants and the need for 
a second surgery. The anodic dissolution of magnesium results in the release of non-toxic 
magnesium ions that can easily be excreted in the urine [17]. In other words, magnesium 
implants can gradually be dissolved, absorbed and excreted after the healing process. 
Therefore, patients would not need a second surgery operation to remove the implant 
[18]. Unfortunately, the rate of magnesium degradation is normally too fast in the initial 
stage after implantation. Therefore, it is important to control the surface degradation of 
biomaterials after implantation into the human body because tissue healing takes time 
[19]. This is illustrated in the Pourbaix diagram of magnesium (Figure 1.1) which shows 
that magnesium has good corrosion resistance in alkaline solution due to the formation of 
a passive Mg(OH)2 film on the surface that is stable in solution of pH > 12. In contrast, 
studies have shown that magnesium is highly degradable in both acidic solution and at 
the neutral pH conditions typically observed in the physiological environment [20]. 
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Figure 1-1: Pourbaix Diagram for Magnesium. [20] 
1.1.3 Mechanical Properties of Magnesium 
There are four major types of biomaterials: metals, polymers, ceramics and glasses [21].  
Some metals play an important role as biomaterials to assist with the repair of bone tissue 
that has been damaged or diseased [8]. Metallic materials are more suitable for load-
bearing applications compared with polymeric or ceramics materials due to their high 
mechanical strength and fracture toughness [19]. Commonly implanted metallic 
biomaterials include stainless steels, titanium and cobalt–chromium-based alloys [19]. 
One of the main drawbacks in using these is their difference in mechanical and physical 
properties in comparison to natural bone tissue which might result in implant failure due 
to the stress shielding effect [8-21]. The stress shielding effect is the reduction in the 
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density of bone tissue due to the removal of the normal stress on the bone after 
implantation. The bone in a healthy person will remodel in response to an applied load. 
Therefore, the bone will become weaker if the loading on bone decreases due to the 
difference in the stiffness between natural bone tissue and the implant material [22]. 
In contrast, magnesium has physical and mechanical properties that are more similar to 
natural bone than traditional metallic implant materials. A brief summary is given in 
Table 1.1 which shows that the density of pure magnesium is approximately 1.74 g/cm
3
, 
it is 1.6 times less dense than aluminum and 4.5 times less dense than steel making it the 
structural metal with a density closest to that of human bone tissue (1.8 g/cm
3
).  
Furthermore, the fracture toughness of magnesium is greater than of ceramic biomaterials 
such as hydroxyapatite. The elastic modulus and compressive yield strength of 
magnesium are also the same order of magnitude as that of natural bone (Table 1.1) [8]. 
These similarities to natural bone should help in reducing or avoiding the stress shielding 
effect thus enhancing stimulation and remodeling of the bone tissue. 
Table 1-1: Summary of the Physical and Mechanical Properties of Various Implant 
Materials in Comparison to Natural Bone [8]. 
Properties Natural 
bone 
Pure 
Magnesium 
Ti alloy Co–Cr 
alloy 
Stainless 
steel 
Synthetic 
hydroxyapatite 
Density (g/cm
3
) 1.8–2.1 1.74–2.0 4.4–4.5 8.3–9.2 7.9–8.1 3.1 
Elastic modulus 
(GPa) 
3–20 41–45 110–117 230 189–205 73–117 
Compressive 
yield strength 
(MPa) 
130–
180 
65–100 758–
1117 
450–
1000 
170–310 600 
Fracture 
toughness 
(MPa/m
1/2
) 
3–6 15–40 55–115 N/A 50–200 0.7 
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 Limitations of Using Magnesium as a Biomaterial 1.2
Application of magnesium as an implant material has been limited due to its high 
corrosion rate in the body fluid and its rapid degradation before the surrounding tissue 
has sufficiently healed [23]. The high degradation rate not only influences tissue healing 
but can also cause the loss of the mechanical integrity of the implant itself before the 
bone tissue has healed sufficiently to be able to bear weight. This can lead to the 
occurrence of a second fracture [24]. Orthopaedic biomaterials require around three to 
four months for bone regeneration. To avoid a second fracture, magnesium alloy implants 
should maintain their mechanical properties for at least three months while the bone 
tissue heals [24]. 
1.2.1 Magnesium Corrosion Resistance 
As stated previously, poor corrosion resistance is the major problem that has limited the 
widespread use of magnesium alloys. The chemical and electrochemical reactivity of 
magnesium alloys are considered high when compared with other structural metals such 
as steels and aluminum alloys. There are two key factors that lead to poor corrosion 
resistance for magnesium alloys. The first is internal galvanic corrosion due to the 
presence of secondary phases or impurities. For magnesium aluminum alloys, the β phase 
consists of second phase particles that precipitate at the grain boundaries during 
solidification. These β phase particles have the stoichiometric composition, Mg17 Al12, 
therefore they are aluminum rich in comparison to the magnesium rich, α phase, of the 
material. Due to the difference in electrochemical potential between the metals, internal 
galvanic coupling can occur resulting in increased corrosion rates [25-26]. The second 
factor leading to poor corrosion resistance is the limited stability of the hydroxide film 
that forms on magnesium surfaces. These hydroxide films are typically less stable than 
passive films that form on other materials such as aluminum alloys and stainless steel 
[27]. 
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1.2.1.1 Corrosion Mechanism of Magnesium in SBF 
The corrosion reaction of pure magnesium in simulated body fluid (SBF) proceeds by an 
electrochemical reaction with water as shown in Reaction Scheme 1.1. This reaction 
produces hydrogen gas, magnesium ions and hydroxide ions leading to an increase in pH 
and ionic strength of the surrounding solution resulting in the precipitation of magnesium 
hydroxide at the sample surface [19-28].  
Reaction Scheme 1.1: General Corrosion Mechanism of Magnesium [28]. 
Anodic reaction:          Mg(s) → Mg
2+
 (aq) + 2e
-
  
Cathodic reaction:       2H2O (l) + 2e
-
 → 2OH-(aq) + H2 (g) 
Product formation:      Mg
2+
 (aq) + 2OH
-
(aq) → Mg(OH) 2(s)  
General reaction:         Mg(s) + 2H2O (l) → Mg(OH) 2(s) + H2 (g)  
The film of Mg(OH)2 that is formed on the surface of the metal can provide protection 
and reduce the corrosion rate of magnesium. However, this film is readily converted into 
soluble MgCl2 in an aqueous environment containing chloride anions according to 
reaction scheme 1.2 [29]. 
Reaction Scheme 1.2: Influence of Anions. 
     Mg(OH)2(s) + 2Cl
-   
                      MgCl2(aq) + 2OH
-
(aq) 
As the hydroxide layer is converted to soluble MgCl2, the underlying substrate is 
continually exposed to the corrosive media resulting in the occurrence of severe pitting of 
the substrate. 
Moreover, some studies have reported that calcium phosphate can be formed on the 
surface of the magnesium alloys exposed to both in vitro and in vivo environments as 
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shown in reaction scheme 1.3. This reaction is oversimplified in that other ions in 
solution such as Mg
2+
 and CO3
2-
 can be substituted into the crystal structure to form 
calcium and phosphate deficient calcium phosphate species.  This has an impact on the 
composition, crystallinity and stability of the formed calcium phosphate layer. This layer 
of calcium phosphate can form in direct contact with the surrounding tissue in vivo and 
can improve both the corrosion rate and the biocompatibility of magnesium in 
physiological solutions [30]. 
Reaction Scheme 1.3: Precipitation Reactions.  
  10Ca
2+
(aq) + 6PO4
3-
(aq) + 2OH
-
(aq) → Ca10 (PO4) 6(OH) 2(s) 
1.2.2 Corrosion Prevention 
Several strategies to obtain suitable degradation rates for orthopedic biomaterials have 
been reported. Some of these strategies include using high purity alloys, addition of new 
alloying elements, surface modification of the alloys, and deposition of protective 
coatings. Examples of surface modification methods include chemical conversion, laser 
modification and anodizing. Protective coatings such as electrochemical plating, 
conversion coatings, hydride coatings, and organic coatings have also been reported [31]. 
The corrosion resistance of magnesium alloys depends on the alloying elements. For 
instance, alloying magnesium with aluminum, generally improves the corrosion 
resistance. The corrosion rate of magnesium alloys decreases rapidly with increasing 
aluminum content due to the formation of the more noble β-phase [32]. However, the 
presence of high concentrations of aluminum can be considered toxic for humans.  
Therefore, it is highly recommended to use magnesium alloys with low concentrations of 
potentially toxic metals in biomaterial applications. Furthermore, the presence of zinc in 
magnesium alloys can increase the tolerance limits and reduce the effect of impurities. In 
addition, it improves strength without reducing flexibility [32-33]. 
The alloy that was used in this project is AZ31, A and Z correspond to aluminum and 
zinc, which are present in the alloy with concentrations of 3 % and 1 % in mass 
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respectively. This alloy has a good combination of suitable mechanical properties, 
corrosion resistance and low concentration of aluminum to serve as a good model 
material to study the influence of surface modification on magnesium alloy corrosion 
rates and bioactivity. 
 Protective and Bioactive Coatings on Magnesium Alloy 1.3
AZ31 
Coatings on biodegradable orthopaedic biomaterial implants should fulfill two main 
purposes: 1. To control the degradation rate of the metal in the body fluids and 2. To be 
able to induce the formation of a hydroxyl apatite layer on the surface of the implant to 
promote good adhesion to the bone tissue [34]. 
In this project, a multi-layered coating consisting of a silica sol-gel under-layer to protect 
the substrate from corrosion in body fluids was coupled with a mesoporous silica top-
layer to enhance the bioactivity of the implanted material. This mesoporous silica top-
layer may also be exploited in the future as a drug delivery system. 
1.3.1 Silane as a Protective Coating 
Creating a barrier between the metal and its physiological environment is the most 
effective way to prevent corrosion of magnesium and its alloys; this can be done through 
the formation of a protective coating. The coating must be uniform, well adhered and 
pore free [31]. The use of silanes to form protective coatings has been successful with 
other implant materials, therefore we hypothesize that this coating strategy may also 
enhance the corrosion resistance of magnesium alloys [35]. 
Many articles have discussed the formation of a covalently bonded protective silica layer 
on a variety of substrates such as magnesium alloys, aluminum alloys, iron, stainless steel 
and other metals [36-37]. Different kinds of silanes have been used to prepare the silica 
coating but alkoxysilane is one of the commonly studied silica sources. These 
alkoxysilanes include both silanes (Si(OR)4) and organosilanes (molecules with at least 
one organic functional group attached directly to the silicon atom, RSi(OR’)3) [37]. 
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Tetraalkoxysilanes are  chemical compound that consists of four alkyl groups attached to 
silicon through oxygen atoms with the formula Si(OR)4 where R can be either CH3 or 
C2H5 [37]. The chemical compound with methyl (CH3) is called tetramethoxysilane 
(TMOS) and the chemical compound with ethyl (C2H5) is tetraethoxysilane (TEOS) [38]. 
TEOS is the silica source that has been used in this project to prepare the silica coating.  
 
Figure 1-2: The Molecular Structure of Tetraethoxysilane (TEOS). 
The methoxy or ethoxy groups of the alkoxysilanes can undergo hydrolysis in the 
presence of water to form silanol groups. The silanol groups can then condense with 
hydroxyl groups on the surface to form covalent bonds leading to improve coating 
integrity and adhesion. In fact, silanes have been commonly used as adhesion promoters 
between inorganic and organic materials [39]. 
The most popular method of preparing the silica film is the sol-gel process as it is an 
environmentally friendly process [40]. Sol-gel coatings have been prepared on many 
different types of substrates including glass, ceramic, magnesium, aluminum, iron and 
other metals [40-42]. Compared to other techniques, the sol-gel technique has several 
advantages that include low cost, excellent adhesion, chemical stability, and good film 
uniformity. Furthermore, it is a simple deposition procedure at carried out at low sintering 
temperature [37-42]. 
The overall sol-gel process consists of two chemical reactions. The first is a hydrolysis 
reaction and the second is a condensation reaction. The hydrolysis reaction produces the 
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sol, while the condensation reaction forms a gel on the substrate producing a thin film 
[43]. 
The interaction of silane with metal surfaces occurs in two steps according to the sol-gel 
process. The first step is the hydrolysis of the silane. This occurs when the alkoxy groups 
react with water to form hydrophilic and reactive silanol groups (Si-OH). An alcohol is 
released as a side product. The second step is the condensation of silane molecules. In 
this step the silanol groups can react with each other to form hydrophobic siloxane bonds 
(Si-O-Si) or they can react with surface hydroxyl groups to form Si-O-Metal bonds. In 
both cases, water is released as a side product [43-44].   The silane precursor does not 
need to undergo complete hydrolysis prior to the start of the condensation reaction; the 
relative rates of hydrolysis and condensation depend on the experimental conditions such 
as the pH of the solution, the concentration of the silane and the availability of water [45]. 
At low pH, the rate of hydrolysis of silane molecules is faster than the rate of 
condensation whereas, at high pH, the rate of hydrolysis is slow and condensation is fast 
[25]. Moreover, an increase of silane concentration also raises the condensation rate thus 
influencing the thickness and uniformity of the deposited film [25]. Hydrolyzed silane 
molecules will react with the surface of metals to form (Si-O-Metal) bonds through 
hydroxyl groups present at the metal surface [43-44]. The surface coupled silane 
molecules can further crosslink with each other through Si-O-Si bonds leading to the 
formation of either a self-assembled monolayer or a multilayer film depending on the 
reaction conditions [25].  A simplified reaction scheme is shown in reaction scheme 1.4.   
The reader should keep in mind that molecules with one, two, three or four silanol groups 
can undergo condensation reactions resulting in a more complex reaction scheme than the 
one shown here.  Furthermore condensation can occur simultaneously between silanol 
groups or with the surface hydroxyl groups. 
Reaction Scheme 1.4: Silane Chemistry [37-43-45]. 
1. The hydrolysis of the silane molecules - (sol formation) 
 Si(OR)4 + 4H2O                              Si(OH)4  + 4ROH 
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2. The condensation of the silane molecules - (gel formation)                                                                                                                                                                                                                                                                                                        
                                                                             OH        OH           
        Si(OH)4  +  Si(OH)4                          HO – Si – O – Si – OH  + H2O 
                                                                             OH        OH    
 
3. The formation of a silane film on metal surfaces                                                                                                           
         OH                   OH                                                             OH        OH          
HO – Si – OH  HO – Si – OH                                             HO – Si – O – Si – OH + 2H2O 
          OH                   OH                                                           O           O  
          OH                   OH                                                                                                              
                                      Self – assembly of the silane film                
Vasconcelos and his group have demonstrated that sol-gel silica coatings can provide 
good corrosion protection for stainless steel in a simple salt solution containing 3.5% 
NaCl [46]. Additionally, previous research has demonstrated that while the sol-gel silica 
coating has excellent corrosion behavior in simulated body fluid it does not have the 
ability to induce apatite formation in-vitro [47]. The ability to induce apatite formation is 
essential for osseointegration of implanted orthopaedic biomaterials. These results 
suggest that a multi-layered coating consisting of a corrosion resistant silica underlayer 
coupled with a bioactive top layer would be a good coating for controlling both the 
degradation rate and bioactivity of magnesium implant materials. 
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1.3.2 Mesoporous Silica as a Bioactive Coating 
1.3.2.1 Overview of Mesoporous Silica Materials 
Porous materials have been classified by IUPAC according to their pore size; macropores 
have a diameter greater than 50 nm, micropores have a diameter less than 2 nm and 
mesopores have a diameter from 2-50 nm. There are many factors that influence the 
formation of mesoporous materials such as the starting materials, type of surfactant and 
reaction conditions (e.g. pH, temperature, solvent, concentration). Mesoporous materials 
can be either ordered or disordered in a mesostructure. The silica structure is disordered 
on the atomic scale; however the pore correlation can be well ordered. The pores can 
have various shapes such as spherical or cylindrical depending on how the materials are 
synthesized [48]. 
Mesoporous silica is an inorganic material synthesized in the presence of a surfactant or a 
block co-polymer, which acts as a template, and a silica precursor molecule. The source 
of the silica precursor can be sodium silicate or alkoxysilanes such as TEOS or TMOS 
[49]. Mesoporous silica materials combine the advantages of both silica and mesoporous 
materials [49-50]. Mobile Crystalline Materials (MCM) was the first family of 
mesoporous materials synthesized in the early 1990’s. These materials were synthesized 
by Kresge and co-workers in the Mobile Corporation laboratories and include both the 
MCM-41and MCM-48 materials. These first mesoporous materials were synthesized 
with a cationic surfactant under basic conditions. In 1998, a new family of mesoporous 
materials was reported by Zhao et al, these were synthesized with non-ionic tri-block 
polymers and are named SBA-X (Santa Barbara Amorphous). Other families of 
mesoporous materials (MSU, FDU, KIT) have since been successfully synthesized using 
various synthesis conditions and templating agents [51-52]. These include MSU 
(Michigan State University) materials that are synthesized by a self-assembly mechanism 
between silica precursors and nonionic poly(ethylene oxide) surfactants [53], FDU which 
has been synthesized by the Zhao group in FuDan University using various neutral 
triblock copolymers in acidic media [52] and KIT (Korea Advanced Institute of Science 
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and Technology) mesoporous silica materials which are also synthesized using triblock 
copolymers as the mesopore-directing agent under acidic conditions [54]. 
1.3.2.2 Synthesis of Mesoporous Silica Materials 
1.3.2.2.1 Synthesis Conditions 
Mesoporous silica materials can be synthesized to have a wide variety of different 
structural features. It is possible to control the particle size, pore size, pore volume, 
surface area, morphology and mesoporosity as well as to incorporate different functional 
groups. These variations allow us to synthesize materials with different physical and 
chemical properties [55]. The synthesis conditions that affect the structural features are 
the type of surfactant, the silica source, the ionic strength and pH of the solution as well 
as the synthesis temperature [56]. 
The nature of the surfactant plays a particularly important role in the synthesis of 
mesoporous silica materials. Pore size mainly depends on the chain length of the 
surfactant, which means that pore diameter increases by increasing the chain length of the 
surfactant [56-57]. Surfactants are amphiphilic molecules. They are composed of a 
hydrophilic head and a hydrophobic tail as shown in Figure 1.3 [58]. Surfactants are 
classified according to their head group which may be cationic, anionic, or nonionic.  
When the surfactant molecules are immersed in an aqueous solution, the hydrophilic head 
of the surfactant moves towards the water or the surrounding solvent and they aggregate 
to form micelles [58]. Examples of surfactants that can be employed in the synthesis of 
mesoporous silica materials are alkyltrimethyl ammonium bromide (cationic), sodium 
alkyl sulfate (anionic) and polyethylene oxide, PEO (non-ionic) [51-52]. The surfactant 
of interest in this project is the cationic surfactant, dodecyltrimethylammonium chloride 
(DTAC). Its molecular structure is illustrated in Figure 1.4. 
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Figure 1-3: Surfactant in Aqueous Solution. 
 
Figure 1-4: The Molecular Structure of Dodecyltrimethylammonium Chloride 
(DTAC) 
1.3.2.2.2 Synthesis Mechanism 
Mesoporous silica materials are synthesized through a combination of the sol-gel and self 
–assembly processes [52]. The mechanism of synthesis for mesoporous silica materials 
can be described by several steps as shown in Figure 1.5 (adapted from [52]). The first 
step involves dissolving the silica precursors into an aqueous solution containing 
surfactant. The silica precursors undergo hydrolysis and condensation to form a sol as 
described in section 1.3.1. In the second step, the surfactants aggregate to form micelles 
followed by self-assembly of the hydrolyzed silica molecules on the micelle surface 
which leads to the formation of silicate-surfactant species. In this way the surfactant 
micelles act as a template for the formation of the silica particles. In the third step, the 
silicate-surfactant species complex into ordered arrays as the silane molecules undergo 
condensation to form silica. Finally, the surfactant must be removed either by calcination 
or solvent extraction to produce the final mesoporous silica structure [52-55]. 
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Figure 1-5: The Synthesis Mechanism of Mesoporous Silica Materials. [52] 
1.3.2.2.3 Application of Mesoporous Silica Materials 
Mesoporous silica materials have received much attention in recent years due to their 
high surface area, large cumulative pore volume, controllable pore size, morphology, and 
easy functionalization [59]. Mesoporous silica materials can be synthesized with different 
pore size by changing the chain length of the hydrophobic group chain in the surfactant 
template molecule [57] or by using the hydrothermal treatment [52]. Hydrothermal 
treatment is a post-synthesis treatment done by adding the as-synthesized mesoporous 
silica materials into an aqueous medium and heating at a particular temperature for a 
period of time. Post-synthesized hydrothermal treatment has been proposed as an 
efficient way for pore expansion and for enhancing hydrothermal stability [60]. The 
overall morphology of mesoporous silica material depends on the type of surfactant used 
[57]. Moreover, mesoporous silica materials can be functionalized for specific 
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applications by incorporating different functional groups such as amine (NH2) and thiol 
(SH) through an appropriate choice of silica precursor [52]. 
Mesoporous silica materials are attractive materials for a wide range of applications.   
They have been studied for use in environmental remediation to adsorb and separate 
specific elements from aqueous solutions. Several studies have demonstrated that 
mesoporous silica materials (MCM-41) which were functionalized with thiol, have a high 
efficiency in terms of removing mercury from aqueous solutions [61-62]. Mesoporous 
silica materials have also been used in chromatographic columns as a stationary phase for 
HPLC [63]. Moreover, mesoporous silica materials have shown promise for use in 
chemical or biological catalysts due to their high surface area which leads to increased 
reaction rates. Other potential applications include nanotechnology, functional devices 
(as a sensor), and biomedical applications such as drug delivery and bone regeneration 
[63]. 
1.3.2.2.4 Biomedical Applications of Mesoporous Silica 
Materials 
Mesoporous silica materials have begun to attract attention for biomedical applications 
due to their high surface areas, high pore volumes, and good biocompatibility.  
A growing area of application for these materials is their application as a biomaterial that 
promotes bone tissue regeneration. In recent years, studies have shown that mesoporous 
silica materials are suitable for use as starting materials for bone tissue engineering 
technologies due to their outstanding properties and biocompatibility [64-65]. The 
nanostructure of these materials is believed to be responsible for their ability to promote 
new bone formation; this is evidenced by:  
1.  The formation of apatite layers on their surface in simulated body fluid which 
indicates that they are bioactive. 
2. The stimulation of osteoblast proliferation and differentiation which 
accelerates the healing process [64]. 
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Izquierdo-Barba, et al. (2005), have reported the formation of an apatite-like layer on the 
mesoporous silica materials SBA-15 and MCM-48 that were soaked in simulated body 
fluid [56]. In addition, another group of researchers demonstrated that osteoblast 
proliferation was promoted by mesoporous silica materials in the early stages of cell 
attachment. They also indicated that an increase in the surface area led to an increase in 
serum protein adsorption and a faster apatite layer formation rate [66]. Recently, Lozano, 
and his research group have shown that both unmodified and organically modified SBA-
15 materials loaded with osteostatin, a parathyroid hormone-related protein (PTHrP) that 
is an important regulator of bone formation and remodeling, increased cell proliferation 
and the expression of several osteoblastic products [67]. 
Furthermore, a study by Katiyar et al. has demonstrated that protein was adsorbed on 
mesoporous silica when these materials were immersed in bovine serum albumin (BSA). 
BSA loading tests have shown that there is a direct dependence of protein adsorption on 
pore size: the greater the pore diameter, the higher the amount of protein loading [68]. 
In addition, several research groups have established that cell uptake and cellular toxicity 
of the mesoporous silica materials are influenced by the particle's size, shape, surface 
charge and functional groups. However, other studies have concluded that no cytotoxicity 
is detected up to 100 μg mL−1 for non-modified 100 nm mesoporous silica particles; this 
is well above the effective concentrations required for most healing treatments [69]. 
Possible toxicity and the mechanism of excretion of mesoporous silica materials in vivo 
were also investigated by injecting mesoporous silica particles into a live mouse tail. The 
test subjects did not show any evidence of toxic effects during the one month study and 
the particles of silica were excreted in the urine [55]. 
In addition to their potential application for bone healing, mesoporous silica materials 
have shown promise as drug delivery-systems [70]. There are numerous examples of 
drug molecules that have been incorporated into mesoporous silica materials. In 2001, 
Vallet-Regi and co-workers were the first researchers that reported the use of mesoporous 
silica materials (MCM-41) as delivery matrices for ibuprofen (an anti-inflammatory drug) 
[71-72]. This led to significant interest in using these materials for drug delivery and 
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several different types of drugs have been successfully loaded into the pores such as 
amoxicillin, gentamicin, aspirin, and erythromycin. The influence of the pore size of the 
mesoporous silica materials on drug delivery rates has also been investigated. The results 
indicated that the delivery rate of ibuprofen in SBF solution decreases as the pore size 
decreases and the higher the surface area, the higher the amount of drug loaded [73]. 
Furthermore, mesoporous silica materials have been effectively used for the delivery of 
anticancer drugs [65]. Moreover, they are one of the most promising drug delivery 
materials in orthopedic surgery; they have been used as implantable drug delivery devices 
for bone tissue to help the healing process by loading antibiotics, growth factors, 
chemotherapeutic agents, antiestrogens, and anti-inflammatory drugs to prevent 
inflammation [71]. 
1.3.2.3 Mesoporous Silica Materials as an Implant Coating 
Mesoporous silica materials have been used as a biomaterial coating on different 
substrates such as titanium, glass and stainless steel due to its biocompatibility and its 
ability to be used as a multifunctional implant coating.  
The biocompatibility of mesoporous silica materials have been confirmed by several 
researchers as discussed in the previous section (1.3.2.2.4). In summary, previous 
publications have shown the biocompatibility of mesoporous silica coatings in several 
ways. The first one involves the formation of hydroxyapatite on its surface which is the 
essential condition for a material to bond with living bone (bioactivity). Gomez-Vega et 
al, (2001) have indicated that mesoporous silica coatings on different substrates (glass, 
silicon, and titanium), can form apatite when they are immersed in a stimulated body 
fluid [74]. The same authors report a multi-layer coating strategy that consists of a 
mesoporous silica film as a second layer on titanium to enhance the bioactivity while 
using a thick glass coating to protect the substrate from corrosion [75]. The second 
evidence of biocompatibility involves the stimulation of osteoblast adhesion, proliferation 
and differentiation which accelerates the healing process. Wang et al, (2010) used a 
mesoporous bioactive glass coating on stainless steel to improve implant-bone 
integration. The authors reported that the mesoporous structure of the coating was 
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responsible for protein adsorption followed by osteoblastic cell attachment, proliferation 
and differentiation [76]. The third evidence of biocompatibility is the non-toxicity and 
non-inflammatory effect to the tissues that was demonstrated by several research groups 
[55-69]. 
In addition to their biocompatibility, mesoporous silica can be used as a multifunctional 
implant coating that acts as a bioactive coating for inert materials and a surface drug 
delivery system at the same time. An example of this is in the incorporation of antibiotics 
into mesoporous silica coatings deposited on implant materials. 
Infection is the most common serious problem associated with medical implants after 
surgical implantation. To prevent infection and inflammation, patients usually take 
antibiotics and anti-inflammatory medications orally, intravenously, intramuscularly or 
topically. However, drugs administered via these routes cannot easily reach the 
implant/tissue interface. Thus, local drug delivery has become a common way to 
eliminate the risk of obtaining infection after implant surgery [77]. For this reason, Ehlert 
and his co-worker have successfully developed a local drug delivery and bioactive 
coating on glass by using mesoporous silica that was loaded with the antibacterial drug 
ciprofloxacin to prevent bacterial infections after implantation [78]. 
 Objectives of the Thesis 1.4
In recent years, magnesium and its alloys have been introduced as a new material of 
interest in the biomaterials research community. They are of particular interest for use as 
an orthopaedic biomaterial due to their excellent biocompatibility, biodegradability, and 
their mechanical properties which are similar to natural bone. One of the major problems 
preventing the widespread use of magnesium alloys is poor corrosion resistance in 
physiological solutions. This decreases the mechanical integrity of the implants in the 
early stages of healing and has a negative impact on the overall biocompatibility. 
Therefore, protective and bioactive coatings are required to improve their corrosion 
resistance and provide optimum biocompatibility in order to achieve ideal degradation 
rates and to maintain the mechanical integrity of the implant during the initial stages of 
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implantation. The use of silanes as protective coatings has been successful with other 
implant materials such as aluminum alloys and steel so the study with magnesium alloys 
may be beneficial as well. Mesoporous silica materials have been shown to have good 
bioactivity and the ability to stimulate osteoblast proliferation and differentiation at 
implant surfaces. Furthermore, they have been shown to be non-toxic and non-
inflammatory to mammalian tissues. Several studies have shown that mesoporous silica 
coatings can be deposited on a variety of different substrates including: titanium, glass, 
and stainless steel. 
Therefore, the specific objectives of this project are to: 
1. To develop a method for depositing a multi-layered bi-functional coating 
consisting of a sol-gel silica protective pre-layer followed by a bioactive 
mesoporous silica film on magnesium alloy AZ31. 
2. To optimize the coating conditions and to characterize the surface chemistry, 
structure and bioactivity of the deposited coatings. 
3. To study the impact of the deposited coatings on the corrosion resistance of the 
magnesium substrate in simulated body fluid (SBF). 
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Chapter 2  
 « Materials and Methods » 2
 Materials 2.1
Disks of magnesium alloy AZ31 (Alfa Aesar) were used in this project as a substrate, the 
composition of the material is listed in Table 2-1. The materials used for polishing were 
purchased from Buehler Canada and included; 320 grit P400 sandpaper, Texmet® 1000 
polishing pads, oil-based lubricant and 9, 3, and 1 micron MetaDi® oil-based diamond 
slurries.  A list of chemicals and their basic properties used in this study is given in Table 
2-2. For the corrosion test, magnesium alloy AZ31 disks were mounted in an epoxy resin; 
a mixture of Buehler's EpoxiCure Epoxy Resin and EpoxiCure Resin Hardener. Hanks 
balanced salt solution was employed as the medium used for both the corrosion test and 
evaluation of the bioactivity (Table 2-3).  
Table 2-1: The Composition (% mass) of Magnesium Alloy AZ31. 
Alloy Mg Al Zn Mn Si Cu Ni Fe 
AZ31 Bal. 3.0 1.0 0.43 0.01 <0.01 <0.001 0.003 
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Table 2-2: Table of Chemicals. 
Compound  Molecular 
Formula 
Molecular 
Weight (g/mol) 
Density 
(g/mL) 
Boiling Point 
(
o
C) 
TEOS SiC8H20O4 208.33  0.933  166-169  
DTAC C15H34ClN 263.89  N/A N/A 
Methanol CH3OH 32.04  0.7918  64.7  
Acetone CH3COCH3 58.90 0.79  56.3  
Deionized 
Water 
H2O 18.02 1.00  100  
Sodium 
Hydroxide 
NaOH 40.00  2.1  318  
Nitric Acid HNO3 63.01  1.5129  109  
Ammonia  NH4OH 35.04  0.91  37.7  
Table 2-3: The Composition of Hanks Balanced Salt Solution. 
Component Concentration (g/L) 
CaCl2. 2H2O 0.185 
MgSO4 (anhyd) 0.09767 
KCl 0.4 
KH2PO4(anhyd) 0.06 
NaHCO3 0.35 
Na2HPO4(anhydrous) 8.0 
D-Glucose 0.04788 
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 Methods 2.2
An overview of the experiments conducted and the experimental method used in this 
thesis is shown in Figure 2.1. In brief, the magnesium alloy AZ31 samples were polished, 
cleaned and alkaline aged. A multi-layer coating was then deposited on the substrate by 
dip coating. The first layer was a sol-gel silica to protect the sample from corrosion. The 
second layer was a mesoporous silica layer to enhance the bioactivity of the material. The 
coating chemistry and morphology were characterized by infrared spectroscopy, scanning 
electron microscopy/energy dispersive spectroscopy analysis and atomic force 
microscopy. The corrosion resistance and bioactivity of the coated samples were 
evaluated via an immersion test in simulated body fluid. Details for each stage of the 
experimental procedure are given in the sections below:    
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Figure 2-1: An Overview of the Experimental Procedure. 
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2.2.1 Polishing AZ31 Mg Alloy 
The AZ31 magnesium alloy samples were polished to a one micron surface finish in 
order to remove the gross oxide layer. The samples were polished in a series of steps. The 
first step was polishing the samples with a 320 Grit P400 sand paper and oil-based 
lubricant. The next step involved polishing the samples with a finer pad using a 9 micron 
diamond suspension for six minutes, followed by a 3 micron diamond suspension for five 
minutes and finally a 1 micron diamond suspension for four minutes. The samples were 
rinsed with water between each step. 
2.2.2 Cleaning 
In order to remove any excess polishing oil from the surface of the alloys, they were 
cleaned with a three step process. In the first step, they were sonicated in acetone for 20 
minutes. In the second step, they were rinsed in deionized water for 30 seconds. Finally 
the samples were air dried. 
2.2.3 Alkaline Aging 
The formation of hydroxyl group on the surface is very important for the covalent bond 
formation between the metal and the sol-gel silica coating. Therefore, the samples were 
immersed into an alkaline bath (0.05M NaOH, pH 12.5) at 50 °C for one hour to promote 
the formation of surface hydroxyl groups. 
2.2.4 Coating Procedures 
2.2.4.1 Sol-gel Silica as a Pre-layer 
The silane coating solutions were prepared by using methanol as the solvent, deionized 
water, ammonia, and TEOS in varying v/v ratio as shown in Table 2.4. The solution was 
allowed to stir for 24 hours to ensure complete hydrolysis before coating. 
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Table 2-4: Sol-Gel Silica Coating Solution Composition 
Coating 
Solution% 
TEOS (mL) Methanol 
(mL) 
Deionized  
Water (mL) 
Ammonia 
(mL) 
3.2  3.2 76.8 14 6 
1.6 1.6 78.4 14 6 
0.8 0.8 79.2 14 6 
0.4 0.4 79.6 14 6 
The samples of AZ31 Mg alloys were immersed into 40 mL of the solutions that were 
prepared using various concentrations of TEOS. The studied concentrations were 0.4, 0.8, 
1.6 and 3.2% (v/v) of TEOS/Solvent. The coating process was optimized at different 
deposition times (20 min, 1, 4 and 24 h) to determine the best coating conditions for 
stable and uniform silane films on the surface of the magnesium alloy. After coating, the 
samples were dried before curing in an oven for 1h at 100 °C. 
2.2.4.2 Deposition of Mesoporous Silica Multilayers 
The mesoporous silica coating solutions were prepared by using TEOS as a silica 
precursor and the cationic surfactant C12TAC (Dodecyltrimethylammonium chloride) as 
the templating agent in deionized water, methanol, and ammonia as the solvent. The 
coating solution was prepared according to [79] with a molar ratio of TEOS: C12TAC: 
deionized water, methanol, and ammonia was 1:0.4:774:1501:72. Therefore, 100 mL of 
methanol was mixed with 0.248 g of C12TAC, 17.7 mL of deionized water, 8 mL of 28% 
aqueous ammonia solution and 0.368 mL of TEOS. The solution was hydrolyzed for 1h 
prior to immersion of the magnesium alloy samples. 
The sol-gel silica coated samples were deposited into the mesoporous silica solutions for 
different deposition times (20 min, 1, 4 and 24 h). In some cases, multiple layers of 
mesoporous silica were deposited by successive immersion of a sol-gel silica coated 
sample in fresh mesoporous silica coating solution. The samples were washed with 
methanol and air dried after each successive layer was deposited. The final coated 
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specimens were cured in an oven at 100 °C for 1 h. After curing, the samples were 
calcined at 350 °C for 3 h followed by gradual cooling of the samples down to room 
temperature in order to remove the surfactant.  
2.2.5 Corrosion Test 
2.2.5.1 Mounting the Discs in Epoxy                                                       
The samples were mounted in epoxy to ensure a uniform surface area and surface 
chemistry for the corrosion test. This was done by mixing five parts of Buehler's 
EpoxiCure Epoxy Resin with one part Epoxicure Resin Hardener for around three 
minutes until the mixture became clear. The mixture was allowed to set for 30 minutes 
until a higher viscosity was achieved. Then the mixture was dropped onto parafilm that 
had been pre-coated with a release agent to facilitate its removal and the coated samples 
were placed into the epoxy and allowed to set overnight. The parafilm was removed prior 
to corrosion testing. 
2.2.5.2 Corrosion Test 
The coated samples were immersed into 25 mL of Simulated Body Fluid (SBF) (Table 2-
3). The samples were stored at 37 °C to mimic in vivo conditions. To compare the 
corrosion rates of the coated samples to the uncoated magnesium alloy, the concentration 
of magnesium ions was measured as a function of time by flame atomic absorbance 
spectroscopy. The solutions were changed daily over a one week period. For each sample, 
a 100 µL aliquot was taken from the corrosion medium and diluted to 10 mL with 2% 
HNO3 in a volumetric flask. Finally, the corroded samples were removed from the 
solution after seven days and they were rinsed with deionized water. The samples were 
dried prior to further analysis. 
2.2.6 Bioactivity Test 
The test was done under the same conditions as the corrosion test described in the 
previous section (2.2.5.2). However, the samples for characterization of the bioactivity 
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were removed from the SBF at different times (1, 3 and 7 days) in order to examine them 
for their ability to induce calcium phosphate formation at the surface. The surface 
chemistry and morphology after immersion in SBF was examined by ATR-FTIR and 
SEM/EDS. 
2.2.7 Instrumental Analysis 
2.2.7.1 Attenuated Total Reflectance – Fourier Transform 
Infrared Microscopy (ATR-FTIR) 
Attenuated Total Reflection Fourier Transform Infrared microscopy (ATR- FTIR) was 
used to analyze the surface of the coated samples after each step. A Bruker Optics 
Hyperion infrared microscope was employed. The main goal of this technique was to 
determine the chemical functional groups present on the surface of the coated magnesium 
alloys. The spectra were taken in three spots for each sample and were corrected with the 
atmospheric compensation function of the software to remove water vapour and CO2 
from the spectra. The determination of the stability and uniformity of the film was also 
determined using this technique. The uniformity was measured by integration of the area 
underneath the peaks for 3 spots on each sample. Larger peak areas were correlated with 
an increase in film thickness at a given location on the sample. Large spot to spot 
standard deviations were assumed to correlate with non-uniformity. The peak chosen for 
this study was the Si-O peaks between 1050 and 1250 cm-1 since they did not overlap 
with any substrate peaks. Furthermore, ATR-FTIR was employed for the identification of 
the corrosion products on the surface of the samples after immersion in SBF.   
In this technique, IR radiation undergoes total internal reflection through an ATR crystal 
which has high refractive index. The total internal reflection results in the formation of an 
evanescent wave, which penetrates into the sample in contact with the crystal. The 
evanescent wave decays exponentially away from the interface making this technique 
somewhat surface sensitive. The resulting spectrum can be used to determine the 
chemical functional groups on the surface [80]. 
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2.2.7.2 Atomic Force Microscope (AFM) 
Atomic force microscope is one type of scanning probe microscope which is used to 
image the topography of surfaces at high resolution and measure the surface forces. 
Atomic force microscope (AFM) was used for characterization of the surface 
morphology of the deposited mesoporous silica coatings. In this research, a Bruker 
multimode AFM III D was used to capture the images in tapping mode. Bruker AFM 
TESPA probes with a resonant frequency of approximately 320 KHz were used. An 
image area of 5 μm x 5 μm was scanned at a scan rate of 0.5 Hz and 512 samples/line.  
2.2.7.3 N2 Adsorption/Desorption 
This technique allows determination of the specific surface area of a sample based on the 
adsorption of nitrogen. This theory is also known as Brunauer-Emmett-Teller (BET). The 
BET gas adsorption method has become the most commonly used for the determination 
of the surface area of porous materials. 
The BET (Brunauer, Emmett and Teller) equation is [81]: 
                                      
Where are na = adsorbed amount, nm = monolayer capacity and C = BET constant. 
The IUPAC classify the adsorption isotherms in six types shown in Figure 2.3 (adapted 
from [80]). The adsorption isotherms are presented as the amount of gas adsorbed on the 
solid plotted versus the relative pressure. The Type I isotherm describe the adsorption 
behavior of microporous adsorbents. Type II isotherms characterize a non-porous or 
macroporous adsorbent. Type III presents adsorption on a macroporous adsorbent with 
weak adsorbate-adsorbent interaction. Type IV isotherms are typically observed for 
mesoporous materials. The observed hysteresis loop is associated with capillary 
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condensation within the mesopores. Type V isotherms also have a hysteresis loop and 
they represent adsorption on porous adsorbents with weak adsorbate-adsorbent 
interactions. Finally, type VI isotherms represent stepwise multilayer adsorption that is 
obtained on a uniform non-porous surface [82]. 
Hysteresis loops are indicative of how the pores are shaped. There are four types of 
hysteresis loops as shown in Figure 2.3 (adapted from [81]). Type H1 is associated with 
uniform spherical particles that have a narrow distribution of pore size. Type H2 
represents porous adsorbents but the distribution of pore size and shape is non-uniform. 
Type H3 is associated with aggregates of plate-like particles that give slit-shaped pores. 
Type H4 is similar to type H3 and is associated with slit-like pores with a narrow pore 
size [82].  
 
Figure 2-2: IUPAC Isotherms Types and Types of Hysteresis Loops. [81] 
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2.2.7.4 Flame Atomic Absorption Spectroscopy (FAAS) 
Flame atomic absorption spectroscopy (FAAS), a Perkin Elmer AA analyst 400, was used 
to compare the corrosion rate of the coated magnesium alloys to the uncoated material. 
This technique was used to measure the concentration of magnesium ions that have been 
released into the solution during the corrosion test. The concentration measurements were 
done by using a calibration curve for standards of known concentrations of magnesium 
(0.05, 0.1, and 0.2 mg/L). An SBF control set was used to compare the concentrations of 
magnesium ions in the SBF solution with the solutions that had been exposed to the 
coated and uncoated magnesium alloy.  
2.2.7.5 Scanning Electron Microscopy-Energy Dispersive X-ray 
Spectroscopy (SEM-EDS) 
Scanning electron microscopy and energy dispersive X-ray spectroscopy (SEM-EDS) 
was used to evaluate the surface morphology and texture of the samples after immersion 
in simulated body fluid. SEM images were obtained using a digital scanning electron 
microscope (JEOL 6400). Energy Dispersive X-ray Spectroscopy (EDS) was used to 
determine the elemental composition of the sample surface. Samples to be analyzed were 
coated with a thin film of carbon to render the sample conductive. The Oxford EDS was 
operated at 20 kV and the beam current of the electron gun was 1 nA.  
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Chapter 3  
 « Results and Discussion » 3
 Optimization of Sol-gel Silica Pre-layer Coating Conditions 3.1
The study of the influence of varying TEOS concentration and deposition time is an 
effective way to optimize the coating conditions for sol-gel silica films deposited on Mg 
alloys. This optimization process allowed us to choose appropriate conditions to produce 
sol-gel silica films with the best uniformity and thickness. The coated samples were 
analyzed by infrared analysis to estimate the variation of thickness and uniformity of the 
sol-gel silica films on the surface. Spectra were collected (3 spots/sample) for magnesium 
alloys coated with solutions containing various TEOS concentration at different 
deposition times. The studied concentrations were 0.4, 0.8, 1.6 and 3.2% of TEOS (v/v, 
TEOS/Solvent). The deposition times studied were 20 min, 1, 4 and 24 h. The variation in 
thicknesses as a function of coating conditions has been estimated by integration of the 
area under the peaks of interest. The size of the error bars (spot to spot variations) 
associated with these measurements has been used to estimate the overall uniformity of 
the deposited coatings. The peak chosen for integration, since they are unaffected by any 
absorptions from the substrate, were the Si-O peaks (1050-1250 cm-1).     
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3.1.1 Control Sample of Magnesium Alloy AZ31 
 
Figure 3-1: IR Spectrum of Mg alloy AZ31 after Surface Pretreatment. 
The surfaces of the magnesium alloy samples were prepared, as described in the 
methodology section. An ATR-FTIR spectrum for a polished, cleaned and alkaline aged 
sample is shown in Figure 3.1. This spectrum has a sharp peak at 3700 cm
-1
 (O-H stretch) 
which indicates the presence of crystalline Mg(OH)2. A broad peak up to 3000 cm
-1
 (O-H 
stretch) was also observed coupled with a peak at 1640 cm
-1
 (O-H bend). Together, the 
presence of these two peaks shows that there is either surface adsorbed water and/or non-
crystalline magnesium hydroxide on the surface. Carbonate (CO3
2-
) is also observed 
(1450 cm
-1
) due to the reaction of the magnesium substrate with carbon dioxide in the 
atmosphere. Furthermore, it can be observed that despite the extensive cleaning regimen, 
peaks at 2850-2930 cm
-1 
(CH2/CH3 stretch) indicating that organic contamination is still 
present on the surface due to adsorption of adventitious carbon from the atmosphere.  
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Figure 3-2: IR Spectrum for TEOS. 
A reference spectrum for pure TEOS is shown in Figure 3.2. Several peaks of particular 
interest have been used to confirm the hydrolysis and condensation of TEOS in the sol-
gel silica coating on the surface of magnesium alloys.  Two regions of particular interest 
are the Si-O stretch at 1050-1250 cm
-1
 and the peaks at 2850-2930 cm
-1 
which are 
attributed to the CH2/CH3 stretch of the ethoxy groups of the unhydrolyzed silane.   On 
the coated samples (Figure 3-3) the peaks at 2850-2930 cm
-1 
have disappeared indicating 
that hydrolysis has occurred and that the coating does not contain unhydrolyzed alkoxy 
groups.   Furthermore, the Si-O stretch from 1050-1250 cm
-1
 has significantly broadened 
due to condensation of the hydrolyzed silane molecule to form Si-O-Mg and Si-O-Si 
bonds.  These peaks were chosen because they occur in regions of the infrared spectrum 
where there is no interference from peaks due to the substrate.  
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3.1.2 Study on the Influence of TEOS Concentration  
 
Figure 3-3: IR Spectra for Sol-gel Silica Coating on Magnesium Alloy AZ31 at 
Various Concentrations of TEOS. 
Figure 3.3 shows representative infrared spectra for magnesium alloy AZ31 disks coated 
with sol-gel silica prepared with various concentrations of TEOS at a constant coating 
deposition time of 20 minutes. The peaks that are indicative of the presence of sol-gel 
silica coating were observed in all of the spectra. The common difference in these spectra 
is the intensity of the peaks. As shown in the figure, the intensity of Si-O peaks increase 
with an increase in TEOS concentration in the coating solution. It is also observed that 
the intensities of the peaks due to the substrate (Mg(OH)2 at 3700 cm
-1
 and O-H bond at 
1640 cm
-1
) decrease with increasing concentration. This increase in peak intensity for 
TEOS peaks coupled with a decrease in the intensity of the substrate peaks indicates that 
the thickness of the coating increases with an increase in TEOS concentration in the 
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coating solution. The peak at 3700 cm
-1 
can be attributed to the presence of either Mg-OH 
or silanol (Si-OH) peaks. However, in this instance the identity of this peak was 
confirmed to be crystalline Mg-OH from the substrate since it was completely unaffected 
even after thermal treatment for 24 hours.  If this peak were due to Si-OH groups, thermal 
treatment would have resulted in further condensation of the Si-OH groups in the coating 
and a concomitant decrease in the peak at 3700 cm
-1
.  
 
 
3.1.3 Study on the Influence of Deposition Time of TEOS 
 
Figure 3-4: IR Spectra for Mg Alloy AZ31 Coated with 3.2% TEOS at Various 
Deposition Times. 
Figure 3.4 shows representative infrared for samples prepared from 3.2% TEOS solution 
as a function of deposition time. It is clear from the figure that the intensity of the Si-O 
peak does not increase with the increasing deposition time from 20 min to 4 h. However, 
the spectrum for long deposition time (24 h) shows an increase in the silicate peak 
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intensity as well as a decrease in the intensity of the magnesium hydroxyl peaks at 3700 
cm
-1
, indicating an increase in the thickness of sol-gel silica film. However, Figure 3.5 
demonstrates that the films deposited at long deposition time are non-uniform. This will 
be discussed in more detail in section 3.1.4 below.   
3.1.4 Study on the Influence of the Deposition Time and TEOS 
Concentration on Thickness and Uniformity of the Sol-gel 
Silica Coating 
 
Figure 3-5: Graph of Silica Peak Areas as a Function of Deposition Time and 
Concentration of TEOS. 
Figure 3.5 is a graph showing the average integrated area under the Si-O peak as a 
function of TEOS concentration and deposition time. The error bars are the spot to spot 
standard deviation in the area under the peak for each sample. Although it is impossible 
to exactly reproduce the contact area of the ATR crystal with the sample surface for each 
measurement, the error bars for 9 different measurements for each sample type are 
relatively small.  This suggests that the trend we have observed is real although an actual 
quantitative value cannot be obtained.  This graph indicates that there is an increase in 
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sol-gel silica coating thickness as a function of TEOS concentration in solution. These 
results further demonstrate that the deposition time does not have a significant effect on 
the thickness of the sol-gel silica coating. However, long deposition times coupled with 
higher TEOS concentration (24 h, 3.2% TEOS) was observed to result in film non-
uniformity as evidenced by the large error bar for this sample. This non-uniformity of the 
film may be due to the reaction conditions. At high concentrations and extended 
deposition times, the condensation reaction between hydrolyzed silane molecules in 
solution may be favoured over condensation of the molecules with surface hydroxyl 
groups. This would result in the formation of oligomers in the solution which 
subsequently attach to the surface rather than multilayer deposition directly at the 
solution/substrate interface. 
From the results obtained, it is clear that the optimum conditions for deposition of the sol-
gel silica protective pre-layer on Mg alloys are high TEOS concentration (3.2% v/v) and 
low deposition time (20 min.) since this gives films with both a maximum thickness and 
good uniformity.   
 Deposition of Mesoporous Silica as a Bioactive Coating 3.2
In order to ensure that magnesium alloys can promote bone re-growth, it is very 
important to ensure that the surface modified material has the ability to induce the 
formation of a hydroxyl apatite layer on its surface. Therefore, the second part of this 
project was to deposit a mesoporous silica coating on magnesium alloy AZ31 to improve 
the bioactivity.  
3.2.1 Optimization of Mesoporous Silica Coating Conditions on 
Bare Magnesium Alloy AZ31 
To determine the best coating condition for mesoporous silica coatings that were 
uniform, stable, and had the ability to form hydroxyapatite on its surface, the effect of 
varying the coating deposition time and the number of treatments (dip coatings) was 
studied. The coated samples were analyzed by infrared microscopy to compare the 
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thickness and uniformity of the mesopourous silica films on the surface of magnesium 
alloys after immersion in the mesoporous silica solution for 20 min, 1, 4 and 24 h. The 
influence of calcination on the as-deposited mesoporous silica films was also studied by 
infrared microscopy. Atomic force microscope (AFM) was used for the characterization 
of surface morphology of mesoporous silica coatings as a function of the number of 
treatments or dips in the coating solution.   
 
Figure 3-6: IR Spectrum for Surfactant on Mg Alloy AZ31 
Figure 3.6 shows the reference infrared spectra for the pure surfactant that was used in 
this project. The important peaks that indicate the presence of the surfactant molecules in 
the deposited coating are the CH2/CH3 stretch peaks at 2850-3000 cm
-1
.   
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Figure 3-7: IR Spectrum for Particles Layers on Mg Alloy AZ31 
A representative infrared spectrum for the as-deposited mesoporous silica layer on bare 
Mg alloy AZ31 is shown in Figure 3.7. There are three peaks of particular interest that 
can be attributed to the presence of the mesoporous silica coating on the surface. The first 
is the (Si-O) peak at 1050-1250 cm
-1 
which indicates the presence of silicate as (Si-O-Si) 
or (Si-O-Mg). The second is the (CH2/CH3) stretch at 2850-3000 cm
-1
 which confirms the 
presence of the templating agent (surfactant) within the coating. The third is the sharp 
peak at 3700 cm
-1 
which may be attributed to either Si-OH or Mg-OH. 
 
42 
 
 
Figure 3-8: IR Spectra of As-Deposited Mesoporous Silica Films at Various 
Deposition Times 
Figure 3.8 shows infrared spectra for magnesium alloys coated with mesoporous silica at 
various deposition times. All of the peaks that are indicative of the presence of a 
mesoporous silica film were observed. Unfortunately, it was observed that the Mg alloy 
began to corrode with increasing deposition time likely due to the presence of the 
chloride anion of the surfactant in the coating bath. The corrosion was observed when the 
deposition time was extended to 4 h. Therefore, it was concluded that the best deposition 
time for the mesoporous silica layer on the Mg alloy was 20 min to 1 h even though the 
overall thickness of the coating was low as evidenced by the low intensity of the infrared 
peaks associated with the coating. In order to improve the thickness of the mesoporous 
silica coating without corrosion of the underlying substrate, multiple treatments/dips in 
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fresh aliquots of the coating solution was performed. Each successive treatment is 
designated as a layer in the discussion below. 
 
Figure 3-9: IR Spectra for Multiple Mesoporous Silica Treatments  
(1h. Deposition Time) 
Figure 3.9 shows infrared spectra for samples successively immersed in the mesoporous 
silica coating solution for three successive 1 h treatments.  It is clear that the mesoporous 
coating is present in all cases and the slight increase in intensity of the Si-O band in these 
spectra may indicate that the coating thickness increased with an increasing number of 
treatments. However, it was still observed that the magnesium alloy began to corrode in 
the coating bath during the third treatment.  
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Figure 3-10: IR Spectra for Multiple Mesoporous Silica Treatments 
 (20 min. Deposition Time) 
Figure 3.10 shows infrared spectra for samples successively immersed in the mesoporous 
silica coating solution for three, 20 minute treatments.  No corrosion of the samples in the 
coating bath was observed even after 3 treatments. 
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Figure 3-11: IR Spectra for Three Different Spots on an As-Deposited Mesoporous 
Silica coating as a function of successive treatments/dips in the coating bath. 
(Deposition time for each layer was 20 min.) 
Figure 3.11 shows representative infrared spectra for three different spots on the as-
deposited mesoporous silica coating prepared by three treatments/dips for a 20 min. 
deposition time per layer. Although, these spectra were collected from different spots on 
the same sample there is no observable difference in the infrared spectra, indicating that 
the deposited mesoporous silica films are uniformly deposited over the whole surface of 
the magnesium alloy substrate. 
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Figure 3-12: 5 µm x 5 µm TM-AFM Images for Magnesium Alloys Coated with as 
Deposited Mesoporous Silica as a Function Number of Treatments/Layers 
 
a)  AFM image for Mg AZ31 (Control)            b)  AFM image for one particle layer,20 min. 
c)  AFM image for two particle layer, 20 min             d)  AFM image for three particle layer, 20 min 
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Atomic Force Microscopy (AFM) was used to determine the structure of the particles that 
were deposited on the surface of the magnesium alloy substrate. The images presented 
are 5 µm x 5 µm. Figure 3.12 shows AFM images for multiple mesoporous silica 
treatments at a 20 minute deposition time per layer. The uncoated, polished magnesium 
AZ31 substrate (Figure 3.12a) shows height variations due to the polishing grooves on 
the surface. Figure 3.12 b shows the magnesium alloy substrate after deposition of a 
single layer of mesoporous silica. Upon comparison to the unmodified surface, it is clear 
that the polishing grooves have become less distinct due to the deposition of spherical 
particles on the surface. The fact that the polishing grooves are still partially visible 
indicates the formation of a thin layer of the mesoporous silica film on the Mg alloy after 
the first treatment. This correlates with the observed infrared spectra which show that the 
intensity of the silica peaks are low after only one layer has been deposited (Figure 3.10).  
Figure 3.12 c shows the AFM image obtained after the substrate was subjected to a 
second treatment in the mesoporous coating solution (addition of a second layer). From 
this image it was observed that after the addition of a second layer of mesoporous silica 
particles, the polishing grooves of the substrate have completely disappeared and there 
are many spherical particles on the surface. This indicates that the film thickness 
increases with the addition of a second layer which correlates with the observed increase 
in silica peak intensity from the infrared spectrum (Figure 3.10). Finally Figure 3.12 d 
shows the AFM image of a sample treated with 3 successively deposited layers of 
mesoporous silica. It is clear from this image that the number of spherical particles 
increases to the point that a uniform layer of mesoporous silica has deposited on the 
surface. The increase in the thickness of the layer was again confirmed by the increase in 
the intensity of the silica bands of the infrared spectra for these samples (Figure 3.10).   
The gradual disappearance of the polishing grooves couples with the increase in the 
number of spherical particles on the surface with the deposition of successive layers  
indicates that three treatments/layers is sufficient to obtain a uniform film of mesoporous 
silica particles on the magnesium alloy substrate.    
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Figure 3-13: IR Spectra for Magnesium Alloys Coated with Multiple Treatments of 
Mesoporous Silica after and before Calcination 
 
Figure 3-14: IR Spectra for Magnesium Alloys Coated with Multiple Treatments of 
Mesoporous Silica after and before Calcination 
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In order to obtain the final mesoporous silica film, the templating agent, in this case a 
surfactant, must be removed after the coating has been deposited on the surface. Figure 
3.13 shows the region of the infrared spectra where the most intense surfactant peaks 
appear (CH2/CH3 stretch, 2850-3000 cm
-1
) before and after calcination.  It was observed 
that the surfactant peaks disappeared completely after calcination of the coated 
magnesium substrate. 
Figure 3.14 shows the infrared spectra before and after calcination from 800 cm
-1
 to 4000 
cm
-1
. No decrease in intensity of the silica peak (1050-1250 cm
-1) 
was observed indicating 
that the thermal treatment does not destroy the deposited mesoporous silica film but only 
removes the surfactant. Moreover, the peak at 3700 cm
-1 
which can be attributed to the 
presence of either Mg-OH or silanol (Si-OH) peaks has completely disappeared after 
calcination.  If this peak were due to crystalline Mg-OH from the substrate it should have 
been largely unaffected by thermal treatment. Therefore, this peak has been attributed to 
Si-OH groups due to incomplete condensation in the mesoporous particles prior to 
thermal treatment. Thermal treatment leads to the condensation/cross-linking of these 
silanol groups converting them to silicate Si-O-Si or Si-O-Mg. 
 Characterization of the Multi-layered, Bi-Functional Coating 3.3
(Sol-gel Silica Coating + Mesoporous Silica Film) 
The key advantages of depositing a multi-layered, bi-functional coating include an 
increase of the corrosion resistance of the magnesium alloy by deposition of a sol-gel 
silica pre-layer followed by a mesoporous silica film to enhance the bioactivity of the 
magnesium alloy substrate.   
The chemistry of the final multi-layered film (sol-gel + mesoporous silica) was confirmed 
by ATR-FTIR. The properties of the mesoporous silica particles (porosity, surface area) 
were determined by N2 adsorption/desorption experiments. 
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Figure 3-15: IR Spectra for the Final Multi-layered Coating (Sol-gel Silica Coating 
+ Mesoporous Silica Film) before and after Calcination 
Figure 3.15 shows infrared spectra for magnesium alloy AZ31 coated with the multi-
layered coating (sol-gel silica coating + multiple treatment of mesoporous silica film) 
before and after calcination. The spectrum for the multi-layered coating before 
calcination indicates that the final film has all the peaks that are indicative of the presence 
of a sol-gel silica layer and the as-deposited mesoporous silica film on the surface of 
magnesium alloy. From the spectra after calcination, it is observed that only the 
surfactant peaks and the Si-OH bands disappear which demonstrates the formation of the 
mesoporous structure and the thermal stability of the overall coating. 
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Figure 3-16: N2 Adsorption/Desorption Isotherms of the Mesoporous Silica Coating 
Figure 3.16 shows the N2 adsorption/desorption isotherms for calcined mesoporous silica 
powder which was collected from the coating solution. This isotherm can be classified as 
a type IV isotherm which is characteristic of mesoporous materials according to the 
IUPAC classification. The isotherm has a large type H2 hysteresis loop which indicates 
the presence of mesopores with a variable size distribution. Brunauer-Emmett-Teller 
(BET) analysis was used to determine the total specific surface area. The BET surface 
area of the coating is approximately 736 ± 19 m²/g. From the results obtained by ATR-
FTIR and N2 adsorption/desorption isotherms, it can be concluded that mesoporous silica 
films with high surface area (due to porosity) were successfully deposited on the 
magnesium alloy substrate.    
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 Corrosion Test (FAAS) 3.4
In order for implants to be successfully integrated into the human body they must be 
biocompatible. The use of magnesium and its alloys as a biomaterial is promising due to 
their good biocompatibility and mechanical properties. However, its degradation rate is 
too high in the first stages of the healing process. Therefore, it is essential to control the 
corrosion behaviour of Mg alloys. 
This study was to determine the corrosion rate of Mg alloys coated with the final multi-
layered coating (sol-gel silica + mesoporous silica film) as well as to identify the 
corrosion products on the surface. Corrosion tests were done by immersing the coated 
substrate in simulated body fluid, Hank’s balanced salt solution. The mechanism of 
chemical corrosion reaction in simulated body fluid is described in the introduction 
(section 1.2.1.1). 
FAAS was used to determine the corrosion rate of coated Mg alloys AZ31 in simulated 
body fluid (SBF) by quantifying the concentration magnesium released into solution as a 
function of time. As described in section 1.2.1.1, magnesium ions will be released into 
solution as the magnesium substrate degrades.  
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Figure 3-17: Amount of Magnesium Dissolved as a Function of Immersion Time in 
SBF 
Atomic absorption spectroscopy was used to determine the corrosion rate of coated Mg 
alloys in SBF compared to the uncoated material. Figure 3.17 is a graph of the 
cumulative amount of magnesium dissolved into the SBF solution as a function of time 
for a 7 day period.  Each data point represents an average of 3 samples; the error bars are 
the sample to sample standard deviations. Up to day 1, the amount of magnesium 
released into solution is the same for both samples. However, by day 2 the uncoated 
material had begun to release magnesium into solution at a high linear rate which 
continued to the end of the study. By day 7, an average of about 1.03 ± 0.05 mg of 
magnesium has been released into the SBF solution.  In comparison, the release of 
magnesium into the SBF solution from the coated sample continued in a linear fashion up 
to 6 days but at a much slower rate than the uncoated sample.  At the 7 day mark there 
appears to be a change in degradation rate of the coated material which may signify that 
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the coating is beginning to break down. However, the total amount of magnesium 
released into solution for the coated samples at 7 days is only about 0.284 ± 0.006 mg. 
This suggests that the uncoated samples degrade at a rate at least 3.5 times greater than 
the coated samples.   
Upon comparison of the coated and uncoated samples, there is a significant difference in 
the rate of degradation which indicates that the multi-layered coating (sol-gel silica 
coating + mesoporous silica film) had a strong influence on the corrosion resistance of 
the magnesium alloy. Longer term studies need to be conducted to determine the 
corrosion resistance of the coated magnesium alloy compared to a control sample over 
several months.  
 Study on the Bioactivity of the Multi-layered Film: 3.5
The formation of hydroxyl apatite on magnesium alloys upon immersion in SBF solution 
(in vitro test) can be a good indication of bioactive behavior in vivo and therefore is often 
used to screen materials for their potential use as bioactive biomaterials. In this study, the 
bioactivity was evaluated by soaking the coated magnesium alloys in SBF solution (Table 
2.3) at 37 °C for different periods of time (1, 3 and 7 days). The ion concentration and pH 
of SBF solution is similar to that of human blood plasma; this solution contains both 
calcium and phosphate ions which make it a simple test for the ability of a biomaterial to 
induce calcium phosphate nucleation and growth at its surface. At each time point, the 
samples were analyzed by SEM-EDS in order to evaluate the morphology and surface 
elemental composition of the uncoated and coated magnesium alloy after immersion in 
SBF. The samples were also analyzed by ATR-FTIR in order to identify the precipitation 
products on the surface and to determine the stability of the multi-layered film after 
immersion in SBF.  
One of the expected outcomes of the immersion of uncoated magnesium in the SBF 
solution is the precipitation of calcium phosphate at the surface of the alloy. Calcium 
phosphates have very low Ksp values, especially at elevated pH. As the magnesium alloy 
degrades, the pH rises resulting in precipitation of calcium phosphate species as shown in 
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reaction scheme 3.1. Since the SBF is supersaturated with calcium and phosphate, this 
reaction readily occurs during immersion in the SBF environment. It could therefore be 
argued that magnesium based implant materials are inherently bioactive. However, the 
calcium phosphate coatings that deposit on the surface via this mechanism are typically 
non-uniform, non-adherent precipitation products that do not impart sufficient corrosion 
resistance to the material. 
Reaction Scheme 3.1: Precipitation Reactions.  
  10Ca
2+
(aq) + 6PO4
3-
(aq) +2OH
-
(aq) → Ca10 (PO4) 6(OH) 2(s) 
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Figure 3-18: SEM Images of Coated and Uncoated Mg AZ31 Alloys after Immersion 
in SBF for Different of Time; (a) Uncoated (b) Coated Sample after 1 Day 
Immersion, (c) Uncoated (d) Coated after 3 Days Immersion, (e) Uncoated (f) 
Coated after 7 Days Immersion 
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 Figure 3.18 shows SEM images of the coated and uncoated magnesium alloys after 
immersion in SBF for different times. It is observed from SEM images (a-c-e) that the 
uncoated sample is completely covered with calcium phosphate layer after immersion in 
SBF for seven days which was expected due to its high corrosion rate which induces 
precipitation of calcium phosphate at the interface. Pitting and cracks are readily 
observed on the magnesium substrate after 1 day and 3 days immersion in SBF.  
Furthermore, non-uniformly distributed calcium phosphate clusters were observed on the 
surface of these samples.  After a 7 day immersion in the SBF solution, the surface of the 
uncoated magnesium alloy was completely covered with a thick layer of calcium 
phosphate. The presence of both calcium and phosphorus on these samples surfaces was 
confirmed by EDS and will be discussed in more detail in subsequent sections. 
In contrast, the SEM images (b-d-f) for the coated sample after immersion in SBF, are 
still smooth after immersion in SBF for one day with the exception of a few small 
calcium phosphate clusters randomly distributed across the surface. After three days of 
immersion in SBF, a uniform layer of calcium phosphate is observed on the surface 
which increases in thickness with increasing immersion time (7 days, Figure 3.18 f). In 
comparison to the uncoated sample this calcium phosphate layer is thin and uniform.    
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Figure 3-19: The Ratio of Calcium/Magnesium after Immersion the Coated and 
Uncoated (Control) Samples in SBF for Different Times 
All the samples were analyzed by EDS for evaluation of elemental composition of the 
new formed bioactive layer on the surface of the coated and uncoated samples.  
Figure 3.19 shows the ratio of Ca/Mg after immersion in SBF as a function of immersion 
time. The EDS analysis suggests that the ratio of calcium/magnesium on the uncoated 
sample surface increases with increasing immersion time in SBF. In comparison, the ratio 
of calcium/magnesium on the coated sample surface is constant for the first three days of 
immersion in SBF and then increases significantly after 7 days indicating an increase in 
the thickness of the calcium phosphate layer with increasing immersion time.   
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Figure 3-20: The Ratio of Silicon/Magnesium after Immersion the Coated Samples 
in SBF for Different Times 
Figure 3.20 shows the ratio of silicon/magnesium after immersion of the coated samples 
in SBF for different times. The average ratios of silicon/magnesium on the coated sample 
are still constant even after a 7 day immersion in SBF. This suggests the multi-layered 
coating has likely not degraded. 
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Figure 3-21: IR Spectra for the Final Multi-layered Coating after Immersion in SBF 
for Various Periods of Time 
Figure 3.21 shows infrared spectra for magnesium alloys coated with the final multi-
layered coating and immersed in SBF for 1, 3 and 7 days. As shown in this figure, both 
the uncoated and coated samples have a strong phosphate peak at 1050 cm
-1
 confirming 
that the phosphorus peak observed in the EDS spectra is due to the presence of phosphate 
at the surface (Table 3.1). The coated samples also have a distinct peak due to silica that 
appears as a shoulder at 1200 cm
-1
. This indicates that the multi-layered coating remains 
intact even after 7 days of exposure to SBF.  
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Table 3-1: The Atomic Percentages of Mg-Si-P-Ca after Immersion the Coated and 
Uncoated (Control) Samples in SBF for Different Times  
Immersion 
Time in 
SBF (Day) 
Sample Magnesium 
(Mg) 
Silicon    
(Si) 
Phosphorous 
(P) 
Calcium 
(Ca) 
1 Control 59.5 ±30.4 _ 2.2±0.3 1.0±0.4 
Coated 66.1±9.1 2±0.5 1.3±0.1 0.5±0.1 
3 Control 45.2±30.2 _ 10.1±9.2 8.2±8.3 
Coated 56.8±9.5 1.8±0.5 2.0±0.5 0.8±0.2 
7 Control 11.7±3.5 _ 8.7±2.3 9.2±3.4 
Coated 41.5±5.1 1.4±0.3 5.4±1.2 2.2±0.7 
The SEM-EDS results coupled with the infrared analysis shown above suggests that the 
coating protects the surface of the magnesium alloy from corrosion in SBF resulting in a 
change in mechanism for calcium phosphate deposition on the coated vs. uncoated 
substrate. On the uncoated substrate, nucleation and growth of the calcium phosphate is 
predominantly due to a rise in pH at the interface resulting in the precipitation of calcium 
phosphate as a corrosion product. On the coated samples the corrosion is minimized and 
nucleation and growth of calcium phosphate may result from local high concentrations of 
calcium and phosphate ions within the pores of the mesoporous silica coating. Further 
studies are needed to confirm this deposition mechanism. However, it is clear from these 
results that the coated magnesium alloy is stable in SBF and bioactive; the deposition of 
calcium phosphate was observed within 1 day of immersion in the SBF solution.     
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Chapter 4  
 « Conclusions and Future Direction » 4
From the results obtained by ATR-FTIR, AFM and N2 adsorption/desorption isotherms, 
it can be concluded that multi-layered coatings were successfully deposited on 
magnesium alloy AZ31 by using silane as a protective pre-layer and mesoporous silica as 
a bioactive coating. The optimum conditions for deposition of the sol-gel silica protective 
pre-layer on Mg alloy were determined to be a high concentration of TEOS (3.2% v/v) 
with a short deposition time (20 min). Furthermore, the optimum mesoporous silica 
coating was obtained by multiple treatments in the coating bath at short deposition times 
to produce multi-layered mesoporous silica film with good uniformity and a high surface 
area.   
The final multi-layered coating (sol-gel silica coating + mesoporous silica film) was 
shown to induce the formation of a calcium phosphate layer on the coated surface in SBF 
indicating its potential as a bioactive coating. In addition, this coating was also observed 
to significantly enhance the corrosion resistance of the magnesium alloy in SBF. 
While these results show that multi-layered, bi-functional coatings can enhance the 
corrosion resistance of magnesium alloys while maintaining their bioactivity further 
research is needed to better understand the mechanism of bioactivity of these coatings. 
Furthermore, in vitro degradation studies to determine the corrosion resistance of these 
coating over longer immersion times in SBF are needed. As well, the behaviour of these 
silica coatings on magnesium alloys in vivo has not been studied. This issue will need to 
be addressed prior to the implementation of these coating in a clinical setting. Finally, the 
possibility of using this mesoporous silica coating as a local drug delivery system should 
be investigated. The potential to load the pores with anti-inflammatory drugs, 
antibacterial agents and possibly growth factors could provide a route to significantly 
improve the overall biocompatibility of magnesium alloy based implant materials.    
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